Buy Turning Point Therapeutics Stock | TPTX Stock Price & Latest News | Public.com
TPTX

Turning Point Therapeutics

$0.00 (0.00%)Today
    View Turning Point Therapeutics (TPTX) stock trends here

    About TPTX

    Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectini...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.34
    -0.68
    -1.03
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$1.03

    Actual EPS
    Q2 2021

    Stats

    Market Cap$3,5B
    Volume170,96k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$141.30
    1 Year Low$46.86
    Open$72.39
    High$73.39
    Low$70.47

    Buy any stock with any amount of money.

    Download the App
    Download the app